NCT03160820View on ClinicalTrials.gov

Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

873

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions
MeaslesMumpsRubellaAdverse Event Following Immunisation
Interventions
BIOLOGICAL

Measles, mumps and rubella Combined Vaccine, Live

Subjects will be inoculated one dose of MMR vaccine and collected blood samples before and after vaccination.

Trial Locations (4)

300011

Tianjin Center for Disease Control and Prevention, Tianjin

050021

Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang

010031

Inner Mongolia Center for Disease Control and Prevention, Hohhot

030012

Shanxi Provincial Center for Disease Control and Prevention, Taiyuan

All Listed Sponsors
collaborator

Beijing Tiantan Biological Products Co., Ltd.

INDUSTRY

lead

Centers for Disease Control and Prevention, China

OTHER_GOV

NCT03160820 - Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine | Biotech Hunter | Biotech Hunter